V025-1372 Screening compound: 4-({[5-benzyl-4-(4-fluorophenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}methyl)-N-(2-methoxyethyl)benzamide

V025-1372 Screening compound: 4-({[5-benzyl-4-(4-fluorophenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}methyl)-N-(2-methoxyethyl)benzamide
V025-1372 Screening compound: 4-({[5-benzyl-4-(4-fluorophenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}methyl)-N-(2-methoxyethyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-1372
4-({[5-benzyl-4-(4-fluorophenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}methyl)-N-(2-methoxyethyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-1372

Molecular Formula

C26H25FN4O2S (C26 H25 FN4 O2 S)

Compound Name

4-({[5-benzyl-4-(4-fluorophenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}methyl)-N-(2-methoxyethyl)benzamide

IUPAC name

4-({[5-benzyl-4-(4-fluorophenyl)-4H-124-triazol-3-yl]sulfanyl}methyl)-N-(2-methoxyethyl)benzamide

SMILES

COCCNC(c1ccc(CSc2nnc(Cc3ccccc3)n2-c(cc2)ccc2F)cc1)=O

InChI

InChI=1S/C26H25FN4O2S/c1-33-16-15-28-25(32)21-9-7-20(8-10-21)18-34-26-30-29-24(17-19-5-3-2-4-6-19)31(26)23-13-11-22(27)12-14-23/h2-14H,15-18H2,1H3,(H,28,32)

InChI Key

HVUSOROFAGNWNY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19785855

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

476.57

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.764

Distribution Coefficient, logD

3.764

Water Solubility, LogSw

-4.08

Polar Surface Area

58.558

Acid Dissociation Constant (pKa)

13.05

Base Dissociation Constant (pKb)

3.84

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

19.20

V025-1372 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V025-1372 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-1372?
Check Price and Availability of V025-1372, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-1372 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-1372
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-1372
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-1372 available by request